ETON Eton Pharmaceuticals, Inc.
$57.08▼ -1.38%
Healthcare
Other
Volume 323.6K
Avg Volume (10D) 489.2K
Key Metrics & Fundamentals
Market Cap
$1.63B
P/E Ratio
146.4
Div Yield
–%
52W Range
14.27 - 66.37
% vs 50 MA
15.32%
% vs 200 MA
96.10%
RSI-14
52.6
MACD Histogram
-1.1700
Beta (1Y vs SPY)
0.12
Free Cash Flow
$7.26M
Gross Rev
$37.59M
Gross Profit
$25.41M
EBITDA
$14.18M
COGS
$12.18M
Operating Exp
$12.62M
Operating Income
$12.79M
EBIT
$12.79M
Pretax Income
$11.72M
Net Income
$11.58M
EPS (Diluted)
0.35
Price & Volume History
Loading chart…
Recent News
Eton Pharmaceuticals Insider Sold Shares Worth $2,953,572, According to a Recent SEC Filing
MT Newswires · Aug 28, 2026 8:56 PM
Jim Cramer Explains Mad Money Caller How to Handle Eton Pharmaceuticals (ETON)
Insider Monkey · Aug 28, 2026 6:39 PM
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference
GlobeNewswire · Aug 27, 2026 10:50 AM
Eton Pharmaceuticals Insider Sold Shares Worth $1,626,750, According to a Recent SEC Filing
MT Newswires · Aug 24, 2026 9:21 PM
TGTX Stock Outperforms 95% of Stocks. Here's Why.
Investor's Business Daily · Aug 24, 2026 4:56 PM
Three Biotech Stocks Stick Out With Their Stellar Charts
Investor's Business Daily · Aug 21, 2026 4:09 PM
Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 20, 2026 11:27 PM
Is Eton Pharmaceuticals (ETON) Fully Priced On Strong Q2 Results And Raised Guidance?
Simply Wall St. · Aug 15, 2026 4:20 AM
Why Top 3% Biotech Stock, Eton, Just Catapulted To A Record High
Investor's Business Daily · Aug 14, 2026 8:10 PM
Sector Update: Healthcare Stocks Decline Late Afternoon
MT Newswires · Aug 14, 2026 7:51 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ETON's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.